Health and Human Services (HHS) Secretary Robert F. Kennedy Jr. today appointed two obstetricians-gynecologists to the ...

The Coalition for Epidemic Preparedness Innovations (CEPI) announced earlier today that the University of Oxford has entered ...

The GARDP Foundation (known as GARDP) and the privately-owned, global biopharmaceutical company Debiopharm today announced that they have entered into a collaboration and license agreement to pursue ...

Gonorrhea is a bigger problem than you think. For years, doctors treating it have watched their options narrow. The bacterium behind the infection, Neisseria gonorrhoeae, has steadily learned to evade ...

The FDA on Friday announced approval of zoliflodacin (Nuzolvence) as an oral treatment for gonorrhea, a day after approving oral gepotidacin (Blujepa) for the same indication. Zoliflodacin is the ...

The Food and Drug Administration (FDA) has approved Nuzolvence ® (zoliflodacin for oral suspension) for the treatment of uncomplicated urogenital gonorrhea in adults and children aged 12 years and ...

Nuzolvence oral granules need to be mixed with water and administered within 15 minutes of mixing. The Food and Drug Administration (FDA) has approved Nuzolvence ® (zoliflodacin for oral suspension) ...

Intracellular Neisseria gonorrhoeae bacteria with gram staining, viewed under a microscope. The U.S. Food and Drug Administration approved two new antibiotics for gonorrhea for the first time in ...

Dec 12 (Reuters) - The U.S. health regulator on Friday approved Innoviva's (INVA.O), opens new tab oral antibiotic to treat gonorrhea, a common sexually transmitted infection, offering patients an ...

For the first time in decades, the U.S. Food and Drug Administration has signed off on new antibiotics to fight gonorrhea. The approvals come at a critical moment: The sexually transmitted infection ...